Recurrent laryngeal nerve monitoring during totally robot-assisted Ivor Lewis esophagectomy.

PURPOSE: The robot-assisted approach for Ivor Lewis esophagectomy offers an enlarged, three-dimensional overview of the intraoperative situs. The vagal nerve (VN) can easily be detected, preserved, and intentionally resected below the separation point of the recurrent laryngeal nerve (RLN). However, postoperative vocal cord paresis can result from vagal or RLN injury during radical lymph node dissection, presenting a challenge to the operating surgeon. METHODS: From May to August 2019, 10 cases of robot-assisted minimally invasive esophagectomy (RAMIE) with extended 2-field lymphadenectomy, performed at the University Medical Center Mainz, were included in a prospective cohort study. Bilateral intermittent intraoperative nerve monitoring (IONM) of the RLN and VN was performed, including pre- and postoperative laryngoscopy assessment. RESULTS: Reliable mean signals of the right VN (2.57 mV/4.50 ms) and the RLN (left 1.24 mV/3.71 ms, right 0.85 mV/3.56 ms) were obtained. IONM facilitated the identification of the exact height of separation of the right RLN from the VN. There were no cases of permanent postoperative vocal paresis. Median lymph node count from the paratracheal stations was 5 lymph nodes. CONCLUSION: IONM was feasible during RAMIE. The intraoperative identification of the RLN location contributed to the accuracy of lymph node dissection of the paratracheal lymph node stations. RLN damage and subsequent postoperative vocal cord paresis can potentially be prevented by IONM.

[MRI in patients with auditory implants equipped with implanted magnets-an update : Overview and procedural management]. / MRT bei Patienten mit Hörimplantaten mit Magnetausstattung ­ ein Update : Überblick und prozedurales Management.

BACKGROUND: More than 100,000 patients with cochlear implants live in Germany. In addition, numerous patients have auditory bone conducted, middle-ear conducted or brainstem conducted implants equipped with implanted magnets. At the same time, the number of patients being examined by magnetic resonance imaging (MRI) is increasing. Therefore, MRI compatibility of these implants is an essential quality feature. METHODS: This article provides information about technical innovations and new auditory devices since November 2013 that have medical-technical certification in the European Union and the USA. We communicate the restrictions of the manufacturers and a selective literature search in PubMed using the following keywords: MRI compatibility/MRI safety + cochlear implant/auditory brainstem implant/Bonebridge/Sophono alpha/Vibrand Soundbridge/BAHA attract. We included all publications of this search concerning MRI compatibility of hearing implants complemented by papers cited in the primary articles. RESULTS: In rare cases, high electromagnetic field intensities as used in MRI can cause shearing movements up to dislocation of the implant or the magnet of the device. As a result the implant function could fail. Image artifacts in head MRIs can be reduced by using appropriate MRI sequences. Nevertheless, possible artifacts and the hereby reduced validity of the skull MRI results have to be considered when indicating the examination. Meanwhile, all innovations of these auditory devices are licensed to 1.5 T MRI examination, some implants up to 3.0 T MRI magnetic field intensity. For older devices, the necessary safety measures listed in the article published by Nospes, Mann and Keilmann in November 2013 should be used. CONCLUSION: Respecting the manufacturer's instructions, MRI scans without removal of the magnet in patients with these auditory implants is safe. However, due to possible defects/dislocations of the implant that may occur and the reduced quality of the skull MRI images, the indication for MRI in devices with MRI certification should only be performed under close consultation between the investigating physicians, the implanting team supervising the patient and the radiologist. All other possible diagnostic procedures should be exhausted first.

[Hearing aid provision in children]. / Hörgeräteversorgung im Kindesalter.

Achieving high-quality hearing aid fitting in children is an interdisciplinary task and a challenge for all involved specialist disciplines. According to quality agreements (standards), comparative hearing aid fitting is mandatory prior to prescription. Furthermore, RECD measurements and, in older children, in-situ measurements should be applied on a regular basis for finetuning and adjustment of the hearing aid fitting. ENT physicians, phoniatricians and pediatric audiologists, pediatric acousticians, teachers of the hearing impaired, and special educational needs teachers should work together in an interdisciplinary approach.

[Symptoms and diagnosis of auditory processing disorder]. / Symptome und Diagnosestellung auditiver Verarbeitungs- und Wahrnehmungsstörungen.

The definition of an auditory processing disorder (APD) is based on impairments of auditory functions. APDs are disturbances in processes central to hearing that cannot be explained by comorbidities such as attention deficit or language comprehension disorders. Symptoms include difficulties in differentiation and identification of changes in time, structure, frequency and intensity of sounds; problems with sound localization and lateralization, as well as poor speech comprehension in adverse listening environments and dichotic situations. According to the German definition of APD (as opposed to central auditory processing disorder, CAPD), peripheral hearing loss or cognitive impairment also exclude APD. The diagnostic methodology comprises auditory function tests and the required diagnosis of exclusion. APD is diagnosed if a patient's performance is two standard deviations below the normal mean in at least two areas of auditory processing. The treatment approach for an APD depends on the patient's particular deficits. Training, compensatory strategies and improvement of the listening conditions can all be effective.

[Hearing disorders in aphasia]. / Hörstörungen bei Aphasie.

Aphasia is an acquired communication disorder that often involves receptive language abilities. After clinical assessment it is often not clear if this is partially due to a hearing loss, which can be compensated by hearing aids facilitating the rehabilitative process.In the present study the hearing ability of 88 male and female patients with aphasia after stroke, all of whom suffered from a left-hemispheric ischemia was assessed in the rehabilitative setting.We found that a majority of patients (72, 82%) was able to perform pure tone audiometry. 15 aphasic patients (21%) showed a hearing loss and were not fitted with hearing aids.Patients with aphasia are due to their central speech disorders in their communication skills limited, so that the therapeutic success is further reduced by an existing hearing loss. Due to the demographic development of our people and with the age increasing prevalence of hearing impairment hearing screening in the post-acute phase in aphasic patients is justified by pure tone audiometry.

Alterations of mucosa of the larynx and hypopharynx in patients with mucopolysaccharidoses.

OBJECTIVE: This study aimed to: assess the mucosal alterations of the larynx and hypopharynx typical for mucopolysaccharidoses, in a standardised manner; compare the severity in different subtypes of mucopolysaccharidoses; and monitor the effect of an enzyme replacement therapy. METHODS: A classification for mucosal alterations of the larynx and hypopharynx was developed and utilised in 55 patients with mucopolysaccharidoses. Fifteen patients who started treatment with enzyme replacement therapy were followed longitudinally. RESULTS: The most severe alterations were seen in the posterior region of the larynx and the arytenoids, and in the region of the false vocal folds. The alterations were most severe in patients with mucopolysaccharidosis II. No clear trend was observed in the patients who received enzyme replacement therapy. CONCLUSION: Quantification of mucosal alterations of the hypopharynx and larynx in mucopolysaccharidoses patients can provide information about the disease's natural process and about the efficacy of enzyme replacement therapy.